Dean Investment Associates’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.73M Buy
96,630
+36,499
+61% +$2.37M 0.81% 31
2025
Q4
$3.71M Buy
+60,131
New +$3.68M 0.53% 94
2024
Q4
Sell
-5,315
Closed -$383K 223
2024
Q3
$383K Sell
5,315
-29,155
-85% -$2.06M 0.05% 208
2024
Q2
$2.37M Sell
34,470
-57,400
-62% -$3.89M 0.34% 141
2024
Q1
$6.67M Buy
91,870
+2,186
+2% +$146K 0.92% 23
2023
Q4
$5.49M Buy
89,684
+32,973
+58% +$1.96M 0.78% 37
2023
Q3
$3.24M Buy
56,711
+9,158
+19% +$553K 0.53% 74
2023
Q2
$2.83M Sell
47,553
-9,368
-16% -$561K 0.46% 81
2023
Q1
$3.56M Sell
56,921
-5,659
-9% -$353K 0.57% 71
2022
Q4
$3.92M Buy
62,580
+8,409
+16% +$482K 0.67% 57
2022
Q3
$2.7M Buy
54,171
+6,312
+13% +$349K 0.55% 71
2022
Q2
$2.81M Sell
47,859
-2,199
-4% -$121K 0.55% 65
2022
Q1
$2.65M Sell
50,058
-1,311
-3% -$75.7K 0.48% 81
2021
Q4
$3.12M Sell
51,369
-11,022
-18% -$654K 0.55% 66
2021
Q3
$3.5M Buy
62,391
+676
+1% +$37.1K 0.66% 43
2021
Q2
$3.21M Buy
61,715
+4,624
+8% +$222K 0.59% 49
2021
Q1
$2.52M Buy
57,091
+14,350
+34% +$603K 0.47% 81
2020
Q4
$1.49M Buy
+42,741
New +$1.52M 0.31% 138

Other funds holding PBH

Dean Investment Associates's PBH Position: Q1 2026 in Review

Dean Investment Associates increased its Prestige Consumer Healthcare (PBH) stake by 61% in Q1 2026, buying an estimated $2.37M and bringing the position to 96,630 shares worth $5.73M. The position accounts for 0.81% of the portfolio, ranked #31.

Dean Investment Associates first reported a position in PBH in Q4 2020 and has held it in 18 quarters since. The position peaked at $6.67M in Q1 2024. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.

  • Dean Investment Associates held 96,630 shares of Prestige Consumer Healthcare worth $5.73M as of Q1 2026.
  • Dean Investment Associates bought 36,499 Prestige Consumer Healthcare shares in Q1 2026, an estimated $2.37M.
  • Prestige Consumer Healthcare made up 0.81% of Dean Investment Associates's portfolio in Q1 2026, its #31 holding.
  • Dean Investment Associates first reported a position in Prestige Consumer Healthcare in Q4 2020 and has held it in 18 quarters since.
  • Dean Investment Associates's Prestige Consumer Healthcare position peaked at $6.67M in Q1 2024.
  • 355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.

Based on Dean Investment Associates's 13F filing for Q1 2026, filed 15 May 2026.